Amgen Inc.
MX ˙ BMV ˙ NL0000888691
SecurityMX:AMGN / Amgen Inc.
InstitutionHighPoint Advisor Group LLC
Latest Disclosed Ownership2,486 shares
Latest Disclosed Value $ 874,555
HighPoint Advisor Group LLC reports 6.56% increase in ownership of AMGN / Amgen Inc.

On May 14, 2026 - HighPoint Advisor Group LLC filed a 13F-HR form disclosing ownership of 2,486 shares of Amgen Inc. (MX:AMGN) valued at $874,555 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on May 14, 2026 disclosing 2,333 shares of Amgen Inc.. This represents a change in shares of 6.56% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F AMGEN Common Stock 031162100 2,486 153 6.56 875 14.55 0.0367
2026-05-14 2025-12-31 13F/A-2 AMGEN Common Stock 031162100 2,333 -9,598 -80.45 763 -77.33 0.0319
2026-02-04 2025-12-31 13F AMGEN Common Stock 031162100 11,960 29 3,914 0.1816
2025-11-05 2025-09-30 13F AMGEN Common Stock 031162100 11,931 72 0.61 3,367 1.66 0.1604
2025-08-07 2025-06-30 13F AMGEN Common Stock 031162100 11,859 262 2.26 3,311 -1.05 0.1759
2025-05-05 2025-03-31 13F AMGEN Common Stock 031162100 11,597 -693 -5.64 3,347 -7.72 0.1948
2025-02-12 2024-12-31 13F AMGEN Common Stock 031162100 12,290 -321 -2.55 3,626 -10.76 0.1970
2024-11-04 2024-09-30 13F AMGEN Common Stock 031162100 12,611 106 0.85 4,063 101,475.00 0.2369
2024-08-08 2024-06-30 13F AMGEN Common Stock 031162100 12,505 1,248 11.09 4 33.33 0.2489
2024-05-14 2024-03-31 13F AMGEN Common Stock 031162100 11,257 333 3.05 3 -99.90 0.2452
2024-03-26 2023-12-31 13F AMGEN Common Stock 031162100 10,924 -231 -2.07 3,068 12.13 0.2197
2022-08-15 2022-06-30 13F AMGEN Common Stock 031162100 11,155 -3,009 -21.24 2,736 -9.16 0.2992
2021-11-15 2021-09-30 13F AMGEN Common Stock 031162100 14,164 654 4.84 3,012 -8.53 0.2951
2021-07-29 2021-06-30 13F AMGEN Common Stock 031162100 13,510 1,059 8.51 3,293 6.23 0.3316
2021-04-12 2021-03-31 13F AMGEN Common Stock 031162100 12,451 -197 -1.56 3,100 3.58 0.3587
2021-02-10 2020-12-31 13F AMGEN Common Stock 031162100 12,648 7,747 158.07 2,993 163.24 0.3645
2020-11-06 2020-09-30 13F AMGEN Common Stock 031162100 4,901 -418 -7.86 1,137 -16.21 0.2057
2020-08-13 2020-06-30 13F AMGEN Common Stock 031162100 5,319 310 6.19 1,357 14.71 0.2901
2020-05-01 2020-03-31 13F/A-2 AMGEN Common Stock 031162100 5,009 -2,763 -35.55 1,183 -35.92 0.2817
2020-04-27 2020-03-31 13F/A-1 AMGEN Common Stock 031162100 1,183 -3,826 5 0.0790
2020-04-27 2020-03-31 13F AMGEN Common Stock 031162100 7,772 0 1,846 379,028.2013
2020-02-13 2019-12-31 13F AMGEN Common Stock 031162100 7,772 2,796 56.19 1,846 67.82 0.3803
2019-11-12 2019-09-30 13F AMGEN Common Stock 031162100 4,976 -625 -11.16 1,100 11.68 0.2431
2019-08-15 2019-06-30 13F/A-1 AMGEN Common Stock 031162100 5,601 -74 -1.30 985 -0.10 0.2306
2019-08-15 2019-06-30 13F AMGEN Common Stock 031162100 5,675 0 986
2019-05-08 2019-03-31 13F AMGEN Common Stock 031162100 5,675 -1,286 -18.47 986 -24.21 0.2414
2019-02-20 2018-12-31 13F AMGEN Common Stock 031162100 6,961 813 13.22 1,301 6.90 0.3446
2018-10-23 2018-09-30 13F AMGEN Common Stock 031162100 6,148 -70 -1.13 1,217 -0.33 0.3332
2018-08-20 2018-06-30 13F AMGEN Common Stock 031162100 6,218 1,705 37.78 1,221 46.75 0.3296
2018-06-11 2018-03-31 13F AMGEN Common Stock 031162100 4,513 -2,089 -31.64 832 -28.40 0.2284
2018-02-15 2017-12-31 13F AMGEN Common Stock 031162100 6,602 -157 -2.32 1,162 -0.26 0.3329
2017-11-06 2017-09-30 13F AMGEN Common Stock 031162100 6,759 993 17.22 1,165 16.27 0.3613
2017-08-15 2017-06-30 13F AMGEN Common Stock 031162100 5,766 0 0.00 1,002 0.00 0.3224
2017-08-07 2017-03-31 13F AMGEN Common Stock 031162100 5,766 2,741 90.61 1,002 85.90 0.3224
2017-03-02 2016-12-31 13F AMGEN Common Stock 031162100 3,025 351 13.13 539 37.15 0.1736
2016-11-21 2016-09-30 13F AMGEN Common Stock 031162100 2,674 89 3.44 393 -11.69 0.1384
2016-08-10 2016-06-30 13F AMGEN Common Stock 031162100 2,585 1,005 63.61 445 72.48 0.1560
2016-04-26 2016-03-31 13F AMGEN Common Stock 031162100 1,580 -47 -2.89 258 1.57 0.1580
2016-01-26 2015-12-31 13F AMGEN COM 031162100 1,627 1,627 254 0.1671
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.